Health Care and Pharmaceuticals Committee hosts an informative discussion on recent antitrust health care and pharmaceutical developments in Europe, including the United Kingdom, Belgium and Italy. Panelists recap recent cases at the CMA involving Pfizer, Flynn, and other companies for unfair pricing as well as their recent investigation into Vifor for unfair competition practices. The panel also recaps recent pharmaceutical cases in belgium and italy and expanding merger control rules in Europe. The panelists discuss patterns they’ve seen in European enforcement in health care and pharmaceuticals and what to expect in the future from these agencies.
The content of this program does not meet requirements for continuing legal education (CLE) accreditation. You will not receive CLE credit for participating.
